Evidence mapPaperPMID 19915016Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

Kristen J Nadeau, Judith G Regensteiner, Timothy A Bauer, Mark S Brown, Jennifer L Dorosz, Amber Hull, Phil Zeitler, Boris Draznin, Jane E B Reusch

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 172 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 5 pooled it
36.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01881828 phase3completedstarted 2013, after this paper: background citation

A Randomized Trial of Metformin as Adjunct Therapy for Overweight Adolescents With Type 1 Diabetes

Ran2013Enrolled164Registered outcomes16Posted comparisons0ConditionsType 1 DiabetesArmsMetformin (glucophage), oral placebo
Open the trial in the graph
NCT02045290 phase3completedstarted 2014, after this paper: background citation

Metformin Therapy for Overweight Adolescents With Type 1 Diabetes (T1D)--Insulin Clamp Ancillary Study for Assessment of Insulin Resistance

Ran2014Enrolled37Registered outcomes3Posted comparisons0ConditionsType 1 DiabetesArmsMetformin, Placebo
Open the trial in the graph
NCT01337947 completednot on this mapstarted 2011, after this paper: background citation

The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes

TypeobservationalSponsorUniversity of VirginiaRan2011 to 2013Enrolled32ConditionsType 1 DiabetesArmsDefinity microbubbles
3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 5 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2019
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kristen J NadeauAssistantUniversity of Colorado Health Sciences Center, The Children's Hospital, Department of Pediatric Endocrinology B265, 13123 East 16th Avenue, Aurora, Colorado 80045, USA. kristen.nadeau@ucdenver.edu
Judith G Regensteiner
Timothy A Bauer
Mark S Brown
Jennifer L Dorosz
Amber Hull
Phil Zeitler
Boris Draznin
Jane E B Reusch
United States Department of Veterans Affairs · USChildren's Hospital Colorado · USColorado School of Public Health · USUniversity of Colorado Denver · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · UNIVERSITY OF COLORADO DENVER · 1985 to 2005
$37.2M
ZORVIRAX ORAL SUSPENSION FOR SEVERE CHILDHOOD HERPES VIRUS INFECTIONSM01RR000069 · UNIVERSITY OF COLORADO DENVER · 1985 to 2005
$15.4M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · UNIVERSITY OF COLORADO DENVER · 2000 to 2005
$7.4M
Treatment Alternatives in Pediatric Type 2 DiabetesU01DK061242 · UNIVERSITY OF COLORADO DENVER · 2001 to 2005
$3.5M
Transcriptional Regulation of PDGF Receptor AlphaR01DK064741 · UNIVERSITY OF COLORADO DENVER · 2004 to 2005
$597k
Insulin Control of Fat Regulation and Exercise in TeensK23RR020038 · UNIVERSITY OF COLORADO DENVER · 2004 to 2005
$263k
NCRR NIH HHS 1 K23 RR020038-01NCRR NIH HHS 5MO1 RR00069NCRR NIH HHS K23 RR020038NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR000069NCRR NIH HHS M01-RR00051NHLBI NIH HHS HL56481NIDDK NIH HHS 5 U01 DK61242-02NIDDK NIH HHS DK 57516NIDDK NIH HHS DK-64741NIDDK NIH HHS F32 DK078413NIDDK NIH HHS F32 DK078413-01NIDDK NIH HHS P30 DK057516NIDDK NIH HHS R01 DK064741NIDDK NIH HHS U01 DK061242
6 · The paper itself

Abstract

contextCardiovascular disease is the major cause of death in adults with diabetes, yet little is specifically known about the effects of type 1 diabetes (T1D) on cardiovascular outcomes in youth. Although insulin resistance (IR) likely contributes to exercise and cardiovascular dysfunction in T2D, IR is not typically considered a contributor in T1D.

objectiveWe hypothesized that cardiopulmonary fitness would be reduced in T1D youth in association with IR and cardiovascular dysfunction. DESIGN AND

participantsThis cross-sectional study at an academic hospital included 12 T1D adolescents compared with 12 nondiabetic controls, similar in age, pubertal stage, activity level, and body mass index. OUTCOME MEASURES: Cardiopulmonary fitness was measured by peak oxygen consumption (VO(2)peak) and oxygen uptake kinetics (VO(2)kinetics), IR by hyperinsulinemic clamp, cardiac function by echocardiography, vascular function by venous occlusion plethysmography, intramyocellular lipid by magnetic resonance spectroscopy, and body composition by dual-energy x-ray absorptiometry.

resultsT1D adolescents had significantly decreased VO(2)peak, peak work rate, and insulin sensitivity compared with nondiabetic adolescents. T1D youth also had reduced vascular reactivity and evidence of diastolic dysfunction and left ventricular hypertrophy. Despite their IR and reduced cardiovascular fitness, T1D youth had paradoxically normal intramyocellular lipid, waist to hip ratio, and serum lipids and high adiponectin levels. In multivariate analysis, IR primarily, and forearm blood flow secondarily, independently predicted VO(2)peak.

conclusionsT1D youth demonstrated IR, impaired functional exercise capacity and cardiovascular dysfunction. The phenotype of IR in T1D youth was unique, suggesting a pathophysiology that is different from T2D, yet may adversely affect long-term cardiovascular outcomes.

Indexed as

HemodynamicsInsulin ResistanceAdolescentBody CompositionCholesterol, LDLCross-Sectional StudiesDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansMaleOxygen ConsumptionCholesterol, LDLGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID19915016
PMCPMC2840859
OpenAlexW2150563156

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.